
Elon Musk’s Secret Weapon: How Mounjaro is Outshining Ozempic in the Weight-Loss Battle
Mounjaro, developed by Eli Lilly, is emerging as a significant competitor to Ozempic in the weight-loss treatment market, driven by its active ingredient, tirzepatide. Clinical studies with 18,000 participants have shown Mounjaro to be more effective in weight loss compared to Ozempic.